Abstract:Background: Endogenous insulin supplementation is essential for individuals with type 1 diabetes (T1D). However, current treatments, including pancreas transplantation, insulin injections, and oral medications, have significant limitations. The development of engineered cells that can secrete endogenous insulin offers a promising new therapeutic strategy for type 1 diabetes (T1D). This approach could potentially circumvent autoimmune responses associated with the transplantation of differentiated β-cells or systemic delivery of viral vectors. Methods: We utilized CRISPR/Cas9 gene editing coupled with homology-directed repair (HDR) to precisely integrate a promoter-free EMCVIRES-insulin cassette into the 3' untranslated region (UTR) of the GAPDH gene in human HEK-293T cells. Subsequently quantified insulin expression levels in these engineered cells, the viability and functionality of the engineered cells when seeded on different cell vectors (GelMA and Cytopore I) were also assessed. Finally, we investigated the therapeutic potential of EMCVIRES-based insulin secretion circuits in reversing Hyperglycaemia in T1D mice. Result: Our results demonstrate that HDR-mediated gene editing successfully integrated the IRES-insulin loop into the genome of HEK-293T cells, a non-endocrine cell line, enabling the expression of human-derived insulin. Furthermore, Cytopore I microcarriers facilitated cell attachment and proliferation during in vitro culture and enhanced cell survival post-transplantation. Transplantation of these cell-laden microcarriers into mice led to the development of a stable, fat-encapsulated structure. This structure exhibited the expression of the platelet-endothelial cell adhesion molecule CD31, and no significant immune rejection was observed throughout the experiment. Diabetic mice that received the cell carriers reversed hyperglycemia, and blood glucose fluctuations under simulated feeding stimuli were very similar to those of healthy mice. Conclusion: In summary, our study demonstrates that Cytopore I microcarriers are biocompatible and promote long-term cell survival in vivo. The promoter-free EMCVIRES-insulin loop enables non-endocrine cells to secrete mature insulin, leading to a rapid reduction in glucose levels. We have presented a novel promoter-free genetic engineering strategy for insulin secretion and proposed an efficient cell transplantation method. Our findings suggest the potential to expand the range of cell sources available for the treatment of diabetes, offering new avenues for therapeutic interventions.

[Regulated Expression of Insulin Gene in Non-Beta Cell].

Establishment of an Artificial Β—cell Line Expressing Insulin under the Control of Doxycycline

Human Insulin Gene Expressing with Bombyx Mori Multiple Nucleopolyhedrovirus (bmmnpv) Expression System

Establishment and detection of a Tet-off stable cell line expressing Egr-1 protein regulated by doxycycline

Mature Insulin Production by Engineered Non-Beta Cells.

Regulated Production of Mature Insulin in Rat Hepatoma Cells: Insulin Production is Up-Regulated by Dexamethasone and Down-Regulated by Insulin

A Study on the Expression of Site-Directed Mutated Human Proinsulin Gene in Non-Β Cell Lines

[Expression of Human Insulin Gene in Vitro and in Vivo].

Construction of a Transgenic Pichia Pastoris Strain Yielding Human Insulin

Recombinant of Green Fluorescent Protein Gene and Human Insulin Gene Allows Efficient Coexpression in HepG2 Cells

Cloning, Expression, and Purification of Recombinant Human-Insulin Analogue Gene in E.coli

Gene therapy for diabetes mellitus:construction and identification of eukaryotic cell expression plasmid in rat proinsulin gene

The Eifference Between the Promoter CMV and EF1#alpha# to the Expression of Human Insulin Gene in BHK Cell

Cloning of CTB-PROIN fusion gene and its expression in Escherichia coli]

Characterization and Oral Delivery of Proinsulin-Transferrin Fusion Protein Expressed Using ExpressTec

Lentiviral Vectors with Amplified Beta Cell-Specific Gene Expression

Genetically Engineered K Cells Provide Sufficient Insulin to Correct Hyperglycemia in a Nude Murine Model.

Engineered IRES-mediated promoter-free insulin-producing cells reverse hyperglycemia

Construction and Identification of Recombinant Vector Carring Conditioner for Human Proinsulin Gene

Construction of Pseudo-B Cell Line by Transfecting Rat Proinsulin Gene to Mouse Intestinal Epithelial Cell

Construction and Identification of Recombinant Adenovirus Harboring the GIP-Human Insulin Gene